Servatus Biopharmaceuticals
Sippy Downs
About Servatus Biopharmaceuticals
Servatus is focused on the development of effective treatments for chronic and inflammatory diseases - especially auto-immune diseases - utilising their proprietary technology. They are engineering "intelligent" directed changes into the structure of select proteins to improve their clinical utility.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.4M
- Last round: Non-Equity Assistance (Jul 2024)
- Website: servatus.com.au
- Phone: +61 7 5430 2206
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/servatus-biopharmaceuticals-160680 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.